Adventures in Generic Drugs

Feb 28, 2009

Generic biotech drugs may be getting a serious boost: part of President Obama's budget is designed to foster development of these follow-on biologics. Over at Patent Baristas, Stephen Albainy-Jenei blogs about the Biotechnology Industry Organization's response at a press conference.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Severity Predictor

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

Pasteur Ends Vaccine Push

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

Shift Younger

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

Cell Studies on COVID-19 Autopsy Proteomics, Human Intestinal Development, Macaque Brain Map

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.

Menu